Advertisement

Latest Update

Medical

Car-T Therapy Ide-Cel For Multiple Myeloma Prolongs Patient Survival By 2-Fold!

Disease

What Do I Need To Do To Check Myself For Nasopharyngeal Carcinoma? What Tests Are Needed To Confirm The Diagnosis Of Nasopharyngeal Carcinoma?

Healthy

How To Manage Dampness And Heat In The Spleen And Stomach

Apparatus

Good Clinical Data For SRF388, An Innovative Lung Cancer Drug, With Patients Stable For

Hospital

Cedars-Sinai Medical Center

How should I choose the first, second and third generation test tube babies?
How To Manage Dampness And Heat In The Spleen And Stomach
Cedars-Sinai Medical Center

Medical see latest

Study Shows That a Blood Pressure Drug Combined With Radiotherapy Improves Outcomes In Locally Advanced Pancreatic Cancer

Study Shows Drug Halves Recurrence Rate In Patients With Early-Stage EGFR-Mutated Lung Cancer!

Integrative Oncology: Acupuncture And Acupressure May Relieve Surgical Pain And Anxiety In Cancer Patients
New Treatment For Lung Cancer Approved! Significantly Better Than Chemotherapy!
MIT | Use artificial intelligence to improve early breast cancer diagnosis
For Fatal Rhabdomyosarcoma, New Atr Inhibitors May Hold Therapeutic Promise

Disease see latest

Atherosclerosis Is a Natural Enemy Of The Middle-Aged And Elderly, How Can It Be Detected Early?

In the early stages of atherosclerotic disease, most patients have almost no clinical symptoms and develop in a latent state of insidiousness.

Can Head And Neck Cancer Recur After Treatment? What Is The Treatment For Recurrence?
What Exactly Are The Symptoms Of An Advanced Brain Tumour? What Are The Physical Signs?
J Thorac Oncol: Survival Differences In Lung Cancer Patients By Gender And The Impact Of Prognostic Factors On Them

Healthy see latest

Excessive exercise tends to accelerate heart failure

What To Eat For Liver Detoxification

What To Do If Your Face Is Red And Peeling And Dry

Apparatus see latest

Ovarian Cancer Heavyweight Cutting-Edge ADC Drug Elahere Proven Safe And Effective

On November 4, 2022, the U.S. FDA has approved the marketing of mivituximab soratansine (Elahere), a cutting-edge antibody-coupled drug targeting folate receptor alpha (FRα), for the treatment of adult patients with epithelial ovarian, fallopian tube or primary peritoneal cancer who have received one to three systemic treatment regimens and are folate receptor alpha (FRα)-positive and platinum-resistant.

Cancer Vaccine Shows Its Power! Survival Of Patients With Advanced Colorectal Cancer Extended By More Than 3 Times!

Genkore Announces Collaboration With Us Company On In Vivo Gene Editing Therapies

Genkore Announces Collaboration With Us Company On In Vivo Gene Editing Therapies
The world's smallest surgical robot "Versius", with a quotation of 2 million pounds
FDA Approves Vabysmo, The First Bispecific Antibody For The Eye!
World's First Antibody Targeting B7H7 Approved For Clinical Trial In The Us
Fda Accepts Zuranolone's Nda Application And Grants It Priority Review For The Treatment Of Mdd And Pdd

Hospital see latest

UCLA Health University of California, Los Angeles Medical Center.
University Of Washington Medical Center
Barnes-Jewish Hospital/Washington University
St. Jude Children's Research Hospital
NYU Langone Hospitals
Keio University Hospital

Tohoku University Hospital, Japan

RECENT ARTICLES

Good Clinical Data For SRF388, An Innovative Lung Cancer Drug, With Patients Stable For

What Do I Need To Do To Check Myself For Nasopharyngeal Carcinoma? What Tests Are Needed To Confirm The Diagnosis Of Nasopharyngeal Carcinoma?
Cedars-Sinai Medical Center
How To Manage Dampness And Heat In The Spleen And Stomach